Cargando…
Late-Onset Immune Thrombocytopenic Purpura After Withdrawal of Interferon Treatment for Chronic Hepatitis C Infection: A Case Report
Immune thrombocytopenic purpura (ITP) is a life-threatening complication following pegylated interferon alpha (PEG-IFN) plus ribavirin treatment, the standard treatment for hepatitis C virus (HCV) infection. We reported a rare case with late-onset ITP after withdrawal of PEG-IFN treatment. A 53-year...
Autores principales: | Hsiao, Chien-Hao, Tseng, Kuo-Chih, Tseng, Chih-Wei, Tung, Chien-Hsueh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602894/ https://www.ncbi.nlm.nih.gov/pubmed/26313770 http://dx.doi.org/10.1097/MD.0000000000001296 |
Ejemplares similares
-
Rapid platelet count improvement in chronic hepatitis C patients with thrombocytopenia receiving direct-acting antiviral agents
por: Chen, Yen-Chun, et al.
Publicado: (2020) -
High Mortality of Cirrhotic Patients With End-Stage Renal Disease
por: Hung, Tsung-Hsing, et al.
Publicado: (2016) -
Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy: Prioritize who needs urgent direct-acting antiviral agents
por: Huang, Chao-Min, et al.
Publicado: (2017) -
Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection
por: Yang, Wan-Ting, et al.
Publicado: (2016) -
Autoimmune Hepatitis Associated with Immune Thrombocytopenic Purpura
por: Ito, Akihiro, et al.
Publicado: (2017)